Medikamentenvergleiche
Exenatide vs. Saxagliptin
Compare Exenatide (Byetta/Bydureon GLP-1 injection) vs Saxagliptin (Onglyza oral DPP-4) for type 2 diabetes: efficacy, weight loss, side effects, and CV risks.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
This comparison is triggered when selecting between an injectable GLP-1 receptor agonist and an oral DPP-4 inhibitor for type 2 diabetes after metformin.
Fazit
Exenatide generally delivers superior glycemic control and weight reduction versus Saxagliptin, though oral convenience and differing safety profiles make the choice highly individual.
Alle Medikamentenvergleiche